Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

This study has been completed.
Information provided by (Responsible Party):
Novo Nordisk A/S Identifier:
First received: December 11, 2006
Last updated: February 18, 2015
Last verified: February 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2006
  Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
No publications provided by Novo Nordisk A/S

Publications automatically indexed to this study by Identifier (NCT Number):